首页 > 最新文献

JMIR Cardio最新文献

英文 中文
High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study. 高通量评估真实世界药物对 QT 间期延长的影响:观察研究。
Q2 Medicine Pub Date : 2023-01-20 DOI: 10.2196/41055
Neal Yuan, Adam Oesterle, Patrick Botting, Sumeet Chugh, Christine Albert, Joseph Ebinger, David Ouyang
<p><strong>Background: </strong>Drug-induced prolongation of the corrected QT interval (QTc) increases the risk for Torsades de Pointes (TdP) and sudden cardiac death. Medication effects on the QTc have been studied in controlled settings but may not be well evaluated in real-world settings where medication effects may be modulated by patient demographics and comorbidities as well as the usage of other concomitant medications.</p><p><strong>Objective: </strong>We demonstrate a new, high-throughput method leveraging electronic health records (EHRs) and the Surescripts pharmacy database to monitor real-world QTc-prolonging medication and potential interacting effects from demographics and comorbidities.</p><p><strong>Methods: </strong>We included all outpatient electrocardiograms (ECGs) from September 2008 to December 2019 at a large academic medical system, which were in sinus rhythm with a heart rate of 40-100 beats per minute, QRS duration of <120 milliseconds, and QTc of 300-700 milliseconds, determined using the Bazett formula. We used prescription information from the Surescripts pharmacy database and EHR medication lists to classify whether a patient was on a medication during an ECG. Negative control ECGs were obtained from patients not currently on the medication but who had been or would be on that medication within 1 year. We calculated the difference in mean QTc between ECGs of patients who are on and those who are off a medication and made comparisons to known medication TdP risks per the CredibleMeds.org database. Using linear regression analysis, we studied the interaction of patient-level demographics or comorbidities on medication-related QTc prolongation.</p><p><strong>Results: </strong>We analyzed the effects of 272 medications on 310,335 ECGs from 159,397 individuals. Medications associated with the greatest QTc prolongation were dofetilide (mean QTc difference 21.52, 95% CI 10.58-32.70 milliseconds), mexiletine (mean QTc difference 18.56, 95% CI 7.70-29.27 milliseconds), amiodarone (mean QTc difference 14.96, 95% CI 13.52-16.33 milliseconds), rifaximin (mean QTc difference 14.50, 95% CI 12.12-17.13 milliseconds), and sotalol (mean QTc difference 10.73, 95% CI 7.09-14.37 milliseconds). Several top QT prolonging medications such as rifaximin, lactulose, cinacalcet, and lenalidomide were not previously known but have plausible mechanistic explanations. Significant interactions were observed between demographics or comorbidities and QTc prolongation with many medications, such as coronary disease and amiodarone.</p><p><strong>Conclusions: </strong>We demonstrate a new, high-throughput technique for monitoring real-world effects of QTc-prolonging medications from readily accessible clinical data. Using this approach, we confirmed known medications for QTc prolongation and identified potential new associations and demographic or comorbidity interactions that could supplement findings in curated databases. Our single-center results wo
背景:药物引起的校正 QT 间期(QTc)延长会增加发生 Torsades de Pointes(TdP)和心脏性猝死的风险。药物对 QTc 的影响已在对照环境中进行了研究,但在实际环境中可能无法很好地评估,因为药物的影响可能受患者人口统计学、合并症以及其他并发症的影响:我们展示了一种新的、高通量的方法,利用电子健康记录(EHR)和 Surescripts 药房数据库监测真实世界中的 QTc 延长药物以及人口统计学和合并症的潜在相互作用:我们纳入了一家大型学术医疗系统从2008年9月至2019年12月的所有门诊心电图(ECG),这些心电图均为窦性心律,心率为每分钟40-100次,QRS持续时间为结果:我们分析了 272 种药物对 159397 人的 310335 张心电图的影响。与最大 QTc 延长相关的药物有多非利特(平均 QTc 差 21.52,95% CI 10.58-32.70 毫秒)、美西律(平均 QTc 差 18.56,95% CI 7.70-29.27毫秒)、胺碘酮(平均QTc差值14.96,95% CI 13.52-16.33毫秒)、利福昔明(平均QTc差值14.50,95% CI 12.12-17.13毫秒)和索他洛尔(平均QTc差值10.73,95% CI 7.09-14.37毫秒)。利福昔明、乳果糖、西那卡西酮和来那度胺等几种最主要的 QT 延长药物以前并不为人所知,但其机理解释是合理的。人口统计学或合并症与许多药物(如冠心病和胺碘酮)的QTc延长之间存在显著的相互作用:我们展示了一种新的、高通量的技术,可从易于获取的临床数据中监测 QTc 延长药物在现实世界中的影响。利用这种方法,我们确认了已知药物对 QTc 延长的影响,并发现了潜在的新关联以及人口统计学或合并症的相互作用,这些都可以补充整理数据库中的发现。未来的多点研究将纳入更多的患者和心电图以及更精确的用药依从性和合并症数据,我们的单中心研究结果将受益于这些研究的进一步验证。
{"title":"High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.","authors":"Neal Yuan, Adam Oesterle, Patrick Botting, Sumeet Chugh, Christine Albert, Joseph Ebinger, David Ouyang","doi":"10.2196/41055","DOIUrl":"10.2196/41055","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Drug-induced prolongation of the corrected QT interval (QTc) increases the risk for Torsades de Pointes (TdP) and sudden cardiac death. Medication effects on the QTc have been studied in controlled settings but may not be well evaluated in real-world settings where medication effects may be modulated by patient demographics and comorbidities as well as the usage of other concomitant medications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;We demonstrate a new, high-throughput method leveraging electronic health records (EHRs) and the Surescripts pharmacy database to monitor real-world QTc-prolonging medication and potential interacting effects from demographics and comorbidities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We included all outpatient electrocardiograms (ECGs) from September 2008 to December 2019 at a large academic medical system, which were in sinus rhythm with a heart rate of 40-100 beats per minute, QRS duration of &lt;120 milliseconds, and QTc of 300-700 milliseconds, determined using the Bazett formula. We used prescription information from the Surescripts pharmacy database and EHR medication lists to classify whether a patient was on a medication during an ECG. Negative control ECGs were obtained from patients not currently on the medication but who had been or would be on that medication within 1 year. We calculated the difference in mean QTc between ECGs of patients who are on and those who are off a medication and made comparisons to known medication TdP risks per the CredibleMeds.org database. Using linear regression analysis, we studied the interaction of patient-level demographics or comorbidities on medication-related QTc prolongation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We analyzed the effects of 272 medications on 310,335 ECGs from 159,397 individuals. Medications associated with the greatest QTc prolongation were dofetilide (mean QTc difference 21.52, 95% CI 10.58-32.70 milliseconds), mexiletine (mean QTc difference 18.56, 95% CI 7.70-29.27 milliseconds), amiodarone (mean QTc difference 14.96, 95% CI 13.52-16.33 milliseconds), rifaximin (mean QTc difference 14.50, 95% CI 12.12-17.13 milliseconds), and sotalol (mean QTc difference 10.73, 95% CI 7.09-14.37 milliseconds). Several top QT prolonging medications such as rifaximin, lactulose, cinacalcet, and lenalidomide were not previously known but have plausible mechanistic explanations. Significant interactions were observed between demographics or comorbidities and QTc prolongation with many medications, such as coronary disease and amiodarone.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;We demonstrate a new, high-throughput technique for monitoring real-world effects of QTc-prolonging medications from readily accessible clinical data. Using this approach, we confirmed known medications for QTc prolongation and identified potential new associations and demographic or comorbidity interactions that could supplement findings in curated databases. Our single-center results wo","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e41055"},"PeriodicalIF":0.0,"publicationDate":"2023-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9212066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and Socioeconomic Differences in Heart Failure Hospitalizations and Telemedicine Follow-up During the COVID-19 Pandemic: Retrospective Cohort Study. COVID-19大流行期间心力衰竭住院和远程医疗随访的种族和社会经济差异:回顾性队列研究
Q2 Medicine Pub Date : 2022-11-28 DOI: 10.2196/39566
Zachary Hughes, Julia Simkowski, Parry Mendapara, Nicolas Fink, Sparsh Gupta, Quentin Youmans, Sadiya Khan, Jane Wilcox, R Kannan Mutharasan

Background: Low rates of heart failure (HF) hospitalizations were observed during the 2020 peak of the COVID-19 pandemic. Additionally, posthospitalization follow-up transitioned to a predominantly telemedicine model. It is unknown whether the shift to telemedicine impacted disparities in posthospitalization follow-up or HF readmissions.

Objective: The aim of this paper is to determine whether the shift to telemedicine impacted racial and ethnic as well as socioeconomic disparities in acute decompensated heart failure (ADHF) follow-up and HF readmissions. We additionally sought to investigate the impact of the COVID-19 pandemic on the severity of ADHF hospitalizations.

Methods: This was a retrospective cohort study of HF admissions across 8 participating hospitals during the initial peak of the COVID-19 pandemic (March 15 to June 1, 2020), compared to the same time frame in 2019. Patients were stratified by race, ethnicity, and median neighborhood income. Hospital and intensive care unit (ICU) admission rates, inpatient mortality, 7-day follow-up, and 30-day readmissions were assessed.

Results: From March 15, 2019, to June 1, 2020, there were 1162 hospitalizations for ADHF included in the study. There were significantly fewer admissions for ADHF in 2020, compared with 2019 (442 vs 720; P<.001). Patients in 2020 had higher rates of ICU admission, compared with 2019 (15.8% vs 11.1%; P=.02). This trend was seen across all subgroups and was significant for patients from the highest income quartile (17.89% vs 10.99%; P=.02). While there was a trend toward higher inpatient mortality in 2020 versus 2019 (4.3% vs 2.8%; P=.17), no difference was seen among different racial and socioeconomic groups. Telemedicine comprised 81.6% of 7-day follow-up in 2020, with improvement in 7-day follow-up rates (40.5% vs 29.6%; P<.001). Inequities in 7-day follow-up for patients from non-Hispanic Black racial backgrounds compared to those from non-Hispanic White backgrounds decreased during the pandemic. Additionally, those with telemedicine follow-up were less likely to be readmitted in 30 days when compared to no follow-up (13.8% vs 22.4%; P=.03).

Conclusions: There were no major differences in HF ICU admissions or inpatient mortality for different racial and socioeconomic groups during the COVID-19 pandemic. Inequalities in 7-day follow-up were reduced with the advent of telemedicine and decreased 30-day readmission rates for those who had telemedicine follow-up.

背景:在2020年COVID-19大流行高峰期,心力衰竭(HF)住院率较低。此外,住院后随访过渡到主要的远程医疗模式。目前尚不清楚向远程医疗的转变是否影响了住院后随访或心衰再入院的差异。目的:本文的目的是确定远程医疗的转变是否会影响急性失代偿性心力衰竭(ADHF)随访和再入院的种族和民族以及社会经济差异。我们还试图调查COVID-19大流行对ADHF住院严重程度的影响。方法:这是一项回顾性队列研究,将8家参与研究的医院在2019年COVID-19大流行的初始高峰期间(2020年3月15日至6月1日)的心衰入院情况与2019年同期进行比较。患者按种族、民族和社区收入中位数进行分层。评估医院和重症监护病房(ICU)住院率、住院死亡率、7天随访和30天再入院率。结果:2019年3月15日至2020年6月1日,研究纳入了1162例ADHF住院病例。与2019年相比,2020年ADHF入院人数明显减少(442人对720人;结论:在2019冠状病毒病大流行期间,不同种族和社会经济群体的心衰ICU住院率和住院死亡率无显著差异。随着远程医疗的出现,7天随访中的不平等现象有所减少,并且远程医疗随访患者的30天再入院率也有所下降。
{"title":"Racial and Socioeconomic Differences in Heart Failure Hospitalizations and Telemedicine Follow-up During the COVID-19 Pandemic: Retrospective Cohort Study.","authors":"Zachary Hughes,&nbsp;Julia Simkowski,&nbsp;Parry Mendapara,&nbsp;Nicolas Fink,&nbsp;Sparsh Gupta,&nbsp;Quentin Youmans,&nbsp;Sadiya Khan,&nbsp;Jane Wilcox,&nbsp;R Kannan Mutharasan","doi":"10.2196/39566","DOIUrl":"https://doi.org/10.2196/39566","url":null,"abstract":"<p><strong>Background: </strong>Low rates of heart failure (HF) hospitalizations were observed during the 2020 peak of the COVID-19 pandemic. Additionally, posthospitalization follow-up transitioned to a predominantly telemedicine model. It is unknown whether the shift to telemedicine impacted disparities in posthospitalization follow-up or HF readmissions.</p><p><strong>Objective: </strong>The aim of this paper is to determine whether the shift to telemedicine impacted racial and ethnic as well as socioeconomic disparities in acute decompensated heart failure (ADHF) follow-up and HF readmissions. We additionally sought to investigate the impact of the COVID-19 pandemic on the severity of ADHF hospitalizations.</p><p><strong>Methods: </strong>This was a retrospective cohort study of HF admissions across 8 participating hospitals during the initial peak of the COVID-19 pandemic (March 15 to June 1, 2020), compared to the same time frame in 2019. Patients were stratified by race, ethnicity, and median neighborhood income. Hospital and intensive care unit (ICU) admission rates, inpatient mortality, 7-day follow-up, and 30-day readmissions were assessed.</p><p><strong>Results: </strong>From March 15, 2019, to June 1, 2020, there were 1162 hospitalizations for ADHF included in the study. There were significantly fewer admissions for ADHF in 2020, compared with 2019 (442 vs 720; P<.001). Patients in 2020 had higher rates of ICU admission, compared with 2019 (15.8% vs 11.1%; P=.02). This trend was seen across all subgroups and was significant for patients from the highest income quartile (17.89% vs 10.99%; P=.02). While there was a trend toward higher inpatient mortality in 2020 versus 2019 (4.3% vs 2.8%; P=.17), no difference was seen among different racial and socioeconomic groups. Telemedicine comprised 81.6% of 7-day follow-up in 2020, with improvement in 7-day follow-up rates (40.5% vs 29.6%; P<.001). Inequities in 7-day follow-up for patients from non-Hispanic Black racial backgrounds compared to those from non-Hispanic White backgrounds decreased during the pandemic. Additionally, those with telemedicine follow-up were less likely to be readmitted in 30 days when compared to no follow-up (13.8% vs 22.4%; P=.03).</p><p><strong>Conclusions: </strong>There were no major differences in HF ICU admissions or inpatient mortality for different racial and socioeconomic groups during the COVID-19 pandemic. Inequalities in 7-day follow-up were reduced with the advent of telemedicine and decreased 30-day readmission rates for those who had telemedicine follow-up.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e39566"},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40480330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Analyzing Public Conversations About Heart Disease and Heart Health on Facebook From 2016 to 2021: Retrospective Observational Study Applying Latent Dirichlet Allocation Topic Modeling. 分析2016年至2021年Facebook上关于心脏病和心脏健康的公众对话:应用潜在狄利克雷分配主题模型的回顾性观察研究
Q2 Medicine Pub Date : 2022-11-22 DOI: 10.2196/40764
Haoning Xue, Jingwen Zhang, Kenji Sagae, Brian Nishimine, Yoshimi Fukuoka

Background: Heart disease continues to be the leading cause of death in men and women in the United States. The COVID-19 pandemic has further led to increases in various long-term cardiovascular complications.

Objective: This study analyzed public conversations related to heart disease and heart health on Facebook in terms of their thematic topics and sentiments. In addition, it provided in-depth analyses of 2 subtopics with important practical implications: heart health for women and heart health during the COVID-19 pandemic.

Methods: We collected 34,885 posts and 51,835 comments spanning from June 2016 to June 2021 that were related to heart disease and health from public Facebook pages and groups. We used latent Dirichlet allocation topic modeling to extract discussion topics illuminating the public's interests and concerns regarding heart disease and heart health. We also used Linguistic Inquiry and Word Count (Pennebaker Conglomerates, Inc) to identify public sentiments regarding heart health.

Results: We observed an increase in discussions related to heart health on Facebook. Posts and comments increased from 3102 and 3632 in 2016 to 8550 (176% increase) and 14,617 (302% increase) in 2021, respectively. Overall, 35.37% (12,340/34,885) of the posts were created after January 2020, the start of the COVID-19 pandemic. In total, 39.21% (13,677/34,885) of the posts were by nonprofit health organizations. We identified 6 topics in the posts (heart health promotion, personal experiences, risk-reduction education, heart health promotion for women, educational information, and physicians' live discussion sessions). We identified 6 topics in the comments (personal experiences, survivor stories, risk reduction, religion, medical questions, and appreciation of physicians and information on heart health). During the pandemic (from January 2020 to June 2021), risk reduction was a major topic in both posts and comments. Unverified information on alternative treatments and promotional content was also prevalent. Among all posts, 14.91% (5200/34,885) were specifically about heart health for women centering on local event promotion and distinctive symptoms of heart diseases for women.

Conclusions: Our results tracked the public's ongoing discussions on heart disease and heart health on one prominent social media platform, Facebook. The public's discussions and information sharing on heart health increased over time, especially since the start of the COVID-19 pandemic. Various levels of health organizations on Facebook actively promoted heart health information and engaged a large number of users. Facebook presents opportunities for more targeted heart health interventions that can reach and engage diverse populations.

背景:心脏病仍然是美国男性和女性死亡的主要原因。COVID-19大流行进一步导致各种长期心血管并发症的增加。目的:本研究分析了Facebook上与心脏病和心脏健康相关的公共对话的主题和情绪。此外,它还深入分析了具有重要实际意义的两个子主题:妇女心脏健康和2019冠状病毒病大流行期间的心脏健康。方法:我们收集了2016年6月至2021年6月期间与心脏病和健康相关的34,885篇帖子和51,835条评论,这些评论来自公共Facebook页面和群组。我们使用潜在的Dirichlet分配主题建模来提取讨论主题,以阐明公众对心脏病和心脏健康的兴趣和关注。我们还使用了语言调查和字数统计(Pennebaker集团公司)来确定公众对心脏健康的看法。结果:我们观察到Facebook上与心脏健康相关的讨论有所增加。文章和评论分别从2016年的3102篇和3632篇增加到2021年的8550篇(增长176%)和14617篇(增长302%)。总体而言,35.37%(12,340/34,885)的职位是在2020年1月COVID-19大流行开始后创建的。共有39.21%(13677 / 34885)的职位是由非营利卫生组织提供的。我们在帖子中确定了6个主题(心脏健康促进、个人经历、降低风险教育、女性心脏健康促进、教育信息和医生现场讨论)。我们在评论中确定了6个主题(个人经历,幸存者故事,降低风险,宗教,医学问题,以及对医生和心脏健康信息的欣赏)。在大流行期间(2020年1月至2021年6月),降低风险是帖子和评论中的一个主要主题。关于替代疗法和宣传内容的未经证实的信息也很普遍。在所有帖子中,14.91%(5200/34,885)是专门关于妇女心脏健康的,主要集中在当地活动宣传和妇女心脏病的独特症状上。结论:我们的研究结果追踪了公众在一个著名的社交媒体平台Facebook上关于心脏病和心脏健康的持续讨论。公众对心脏健康的讨论和信息共享随着时间的推移而增加,特别是自COVID-19大流行开始以来。各级卫生组织在Facebook上积极推广心脏健康信息,吸引了大量用户。Facebook为更有针对性的心脏健康干预提供了机会,可以接触到不同的人群。
{"title":"Analyzing Public Conversations About Heart Disease and Heart Health on Facebook From 2016 to 2021: Retrospective Observational Study Applying Latent Dirichlet Allocation Topic Modeling.","authors":"Haoning Xue,&nbsp;Jingwen Zhang,&nbsp;Kenji Sagae,&nbsp;Brian Nishimine,&nbsp;Yoshimi Fukuoka","doi":"10.2196/40764","DOIUrl":"https://doi.org/10.2196/40764","url":null,"abstract":"<p><strong>Background: </strong>Heart disease continues to be the leading cause of death in men and women in the United States. The COVID-19 pandemic has further led to increases in various long-term cardiovascular complications.</p><p><strong>Objective: </strong>This study analyzed public conversations related to heart disease and heart health on Facebook in terms of their thematic topics and sentiments. In addition, it provided in-depth analyses of 2 subtopics with important practical implications: heart health for women and heart health during the COVID-19 pandemic.</p><p><strong>Methods: </strong>We collected 34,885 posts and 51,835 comments spanning from June 2016 to June 2021 that were related to heart disease and health from public Facebook pages and groups. We used latent Dirichlet allocation topic modeling to extract discussion topics illuminating the public's interests and concerns regarding heart disease and heart health. We also used Linguistic Inquiry and Word Count (Pennebaker Conglomerates, Inc) to identify public sentiments regarding heart health.</p><p><strong>Results: </strong>We observed an increase in discussions related to heart health on Facebook. Posts and comments increased from 3102 and 3632 in 2016 to 8550 (176% increase) and 14,617 (302% increase) in 2021, respectively. Overall, 35.37% (12,340/34,885) of the posts were created after January 2020, the start of the COVID-19 pandemic. In total, 39.21% (13,677/34,885) of the posts were by nonprofit health organizations. We identified 6 topics in the posts (heart health promotion, personal experiences, risk-reduction education, heart health promotion for women, educational information, and physicians' live discussion sessions). We identified 6 topics in the comments (personal experiences, survivor stories, risk reduction, religion, medical questions, and appreciation of physicians and information on heart health). During the pandemic (from January 2020 to June 2021), risk reduction was a major topic in both posts and comments. Unverified information on alternative treatments and promotional content was also prevalent. Among all posts, 14.91% (5200/34,885) were specifically about heart health for women centering on local event promotion and distinctive symptoms of heart diseases for women.</p><p><strong>Conclusions: </strong>Our results tracked the public's ongoing discussions on heart disease and heart health on one prominent social media platform, Facebook. The public's discussions and information sharing on heart health increased over time, especially since the start of the COVID-19 pandemic. Various levels of health organizations on Facebook actively promoted heart health information and engaged a large number of users. Facebook presents opportunities for more targeted heart health interventions that can reach and engage diverse populations.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e40764"},"PeriodicalIF":0.0,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40438111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The First National Program of Remote Cardiac Rehabilitation in Israel-Goal Achievements, Adherence, and Responsiveness in Older Adult Patients: Retrospective Analysis. 以色列第一个国家远程心脏康复项目——老年患者的目标成就、依从性和反应性:回顾性分析。
Q2 Medicine Pub Date : 2022-11-16 DOI: 10.2196/36947
Irene Nabutovsky, Daniel Breitner, Alexis Heller, Mickey Scheinowitz, Yarin Klempfner, Robert Klempfner

Background: Remote cardiac rehabilitation (RCR) after myocardial infarction is an innovative Israeli national program in the field of telecardiology. RCR is included in the Israeli health coverage for all citizens. It is generally accepted that telemedicine programs better apply to younger patients because it is thought that they are more technologically literate than are older patients. It has also previously been thought that older patients have difficulty using technology-based programs and attaining program goals.

Objective: The objectives of this study were as follows: to study patterns of physical activity, goal achievement, and improvement in functional capacity among patients undergoing RCR over 65 years old compared to those of younger patients; and to identify predictors of better adherence with the RCR program.

Methods: A retrospective study of patients post-myocardial infarction were enrolled in a 6-month RCR program. The activity of the patients was monitored using a smartwatch. The data were collected and analyzed by a special telemedicine platform. RCR program goals were as follows: 150 minutes of aerobic activity per week, 120 minutes of the activity in the target heart rate recommended by the exercise physiologist, and 8000 steps per day. Models were created to evaluate variables predicting adherence with the program.

Results: Out of 306 patients, 80 were older adults (mean age 70 years, SD 3.4 years). At the end of the program, there was a significant improvement in the functional capacity of all patients (P=.002). Specifically, the older adult group improved from a mean 8.1 (SD 2.8) to 11.2 (SD 12.6). The metabolic equivalents of task (METs) and final MET results were similar among older and younger patients. During the entire program period, the older adult group showed better achievement of program goals compared to younger patients (P=.03). Additionally, we found that younger patient age is an independent predictor of early dropout from the program and completion of program goals (P=.045); younger patients were more likely to experience early program dropout and to complete fewer program goals.

Conclusions: Older adult patients demonstrated better compliance and achievement of the goals of the remote rehabilitation program in comparison with younger patients. We found that older age is not a limitation but rather a predictor of better RCR program compliance and program goal achievement.

背景:心肌梗死后远程心脏康复(RCR)是以色列在心脏远程学领域的一项创新性国家项目。RCR被纳入以色列所有公民的医疗保险。人们普遍认为,远程医疗项目更适用于年轻患者,因为他们被认为比年长患者更懂技术。以前人们还认为,老年患者在使用基于技术的项目和实现项目目标方面存在困难。目的:本研究的目的如下:研究65岁以上RCR患者与年轻患者相比的身体活动模式、目标实现和功能能力改善;并确定更好地遵守RCR计划的预测因素。方法:对心肌梗死后患者进行为期6个月的RCR研究。通过智能手表监测患者的活动。数据收集和分析由一个专门的远程医疗平台。RCR计划的目标如下:每周进行150分钟的有氧运动,以运动生理学家推荐的目标心率进行120分钟的运动,每天8000步。建立模型来评估预测项目依从性的变量。结果:306例患者中,80例为老年人(平均年龄70岁,SD 3.4岁)。在项目结束时,所有患者的功能能力都有显著改善(P= 0.002)。具体而言,老年人组从平均8.1 (SD 2.8)改善到11.2 (SD 12.6)。任务代谢当量(METs)和最终MET结果在老年和年轻患者中相似。在整个项目期间,与年轻患者相比,老年人组表现出更好的项目目标实现情况(P=.03)。此外,我们发现年轻的患者年龄是早期退出计划和完成计划目标的独立预测因子(P= 0.045);年轻的患者更有可能经历早期的计划退出,完成更少的计划目标。结论:与年轻患者相比,老年患者表现出更好的依从性和实现远程康复计划的目标。我们发现年龄不是限制,而是更好的RCR计划依从性和计划目标实现的预测因子。
{"title":"The First National Program of Remote Cardiac Rehabilitation in Israel-Goal Achievements, Adherence, and Responsiveness in Older Adult Patients: Retrospective Analysis.","authors":"Irene Nabutovsky,&nbsp;Daniel Breitner,&nbsp;Alexis Heller,&nbsp;Mickey Scheinowitz,&nbsp;Yarin Klempfner,&nbsp;Robert Klempfner","doi":"10.2196/36947","DOIUrl":"https://doi.org/10.2196/36947","url":null,"abstract":"<p><strong>Background: </strong>Remote cardiac rehabilitation (RCR) after myocardial infarction is an innovative Israeli national program in the field of telecardiology. RCR is included in the Israeli health coverage for all citizens. It is generally accepted that telemedicine programs better apply to younger patients because it is thought that they are more technologically literate than are older patients. It has also previously been thought that older patients have difficulty using technology-based programs and attaining program goals.</p><p><strong>Objective: </strong>The objectives of this study were as follows: to study patterns of physical activity, goal achievement, and improvement in functional capacity among patients undergoing RCR over 65 years old compared to those of younger patients; and to identify predictors of better adherence with the RCR program.</p><p><strong>Methods: </strong>A retrospective study of patients post-myocardial infarction were enrolled in a 6-month RCR program. The activity of the patients was monitored using a smartwatch. The data were collected and analyzed by a special telemedicine platform. RCR program goals were as follows: 150 minutes of aerobic activity per week, 120 minutes of the activity in the target heart rate recommended by the exercise physiologist, and 8000 steps per day. Models were created to evaluate variables predicting adherence with the program.</p><p><strong>Results: </strong>Out of 306 patients, 80 were older adults (mean age 70 years, SD 3.4 years). At the end of the program, there was a significant improvement in the functional capacity of all patients (P=.002). Specifically, the older adult group improved from a mean 8.1 (SD 2.8) to 11.2 (SD 12.6). The metabolic equivalents of task (METs) and final MET results were similar among older and younger patients. During the entire program period, the older adult group showed better achievement of program goals compared to younger patients (P=.03). Additionally, we found that younger patient age is an independent predictor of early dropout from the program and completion of program goals (P=.045); younger patients were more likely to experience early program dropout and to complete fewer program goals.</p><p><strong>Conclusions: </strong>Older adult patients demonstrated better compliance and achievement of the goals of the remote rehabilitation program in comparison with younger patients. We found that older age is not a limitation but rather a predictor of better RCR program compliance and program goal achievement.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e36947"},"PeriodicalIF":0.0,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40688313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Use of Dietary Approaches to Stop Hypertension (DASH) Mobile Apps for Supporting a Healthy Diet and Controlling Hypertension in Adults: Systematic Review. 使用饮食方法来停止高血压(DASH)移动应用程序支持健康饮食和控制成人高血压:系统综述。
Q2 Medicine Pub Date : 2022-11-02 DOI: 10.2196/35876
Ghadah Alnooh, Tourkiah Alessa, Mark Hawley, Luc de Witte

Background: Uncontrolled hypertension is a public health issue, with increasing prevalence worldwide. The Dietary Approaches to Stop Hypertension (DASH) diet is one of the most effective dietary approaches for lowering blood pressure (BP). Dietary mobile apps have gained popularity and are being used to support DASH diet self-management, aiming to improve DASH diet adherence and thus lower BP.

Objective: This systematic review aimed to assess the effectiveness of smartphone apps that support self-management to improve DASH diet adherence and consequently reduce BP. A secondary aim was to assess engagement, satisfaction, acceptance, and usability related to DASH mobile app use.

Methods: The Embase (OVID), Cochrane Library, CINAHL, Web of Science, Scopus, and Google Scholar electronic databases were used to conduct systematic searches for studies conducted between 2008 and 2021 that used DASH smartphone apps to support self-management. The reference lists of the included articles were also checked. Studies were eligible if they (1) were randomized controlled trials (RCTs) or pre-post studies of app-based interventions for adults (aged 18 years or above) with prehypertension or hypertension, without consideration of gender or sociodemographic characteristics; (2) used mobile phone apps alone or combined with another component, such as communication with others; (3) used or did not use any comparator; and (4) had the primary outcome measures of BP level and adherence to the DASH diet. For eligible studies, data were extracted and outcomes were organized into logical categories, including clinical outcomes (eg, systolic BP, diastolic BP, and weight loss), DASH diet adherence, app usability and acceptability, and user engagement and satisfaction. The quality of the studies was evaluated using the Cochrane Collaboration's Risk of Bias tool for RCTs, and nonrandomized quantitative studies were evaluated using a tool provided by the US National Institutes of Health.

Results: A total of 5 studies (3 RCTs and 2 pre-post studies) including 334 participants examined DASH mobile apps. All studies found a positive trend related to the use of DASH smartphone apps, but the 3 RCTs had a high risk of bias. One pre-post study had a high risk of bias, while the other had a low risk. As a consequence, no firm conclusions could be drawn regarding the effectiveness of DASH smartphone apps for increasing DASH diet adherence and lowering BP. All the apps appeared to be acceptable and easy to use.

Conclusions: There is weak emerging evidence of a positive effect of using DASH smartphone apps for supporting self-management to improve DASH diet adherence and consequently lower BP. Further research is needed to provide high-quality evidence that can determine the effectiveness of DASH smartphone apps.

背景:不受控制的高血压是一个公共卫生问题,在世界范围内的患病率越来越高。饮食降压法(DASH)是最有效的降压方法之一。饮食移动应用程序越来越受欢迎,并被用于支持DASH饮食自我管理,旨在提高DASH饮食的依从性,从而降低血压。目的:本系统综述旨在评估智能手机应用程序支持自我管理的有效性,以提高DASH饮食依从性,从而降低血压。第二个目的是评估与DASH移动应用程序使用相关的参与度、满意度、接受度和可用性。方法:采用Embase (OVID)、Cochrane Library、CINAHL、Web of Science、Scopus和Google Scholar电子数据库对2008年至2021年间使用DASH智能手机应用程序支持自我管理的研究进行系统检索。还检查了纳入文章的参考文献列表。研究符合以下条件:(1)随机对照试验(rct)或基于app的高血压前期或高血压成人(18岁或以上)干预的前后研究,不考虑性别或社会人口学特征;(2)单独使用或与其他组件结合使用手机应用程序,如与他人通信;(三)使用或者未使用比较器的;(4)主要结局指标为血压水平和DASH饮食依从性。对于符合条件的研究,提取数据并将结果按逻辑分类,包括临床结果(如收缩压、舒张压和体重减轻)、DASH饮食依从性、应用程序可用性和可接受性、用户参与度和满意度。使用Cochrane协作组织的随机对照试验偏倚风险工具评估研究的质量,使用美国国立卫生研究院提供的工具评估非随机定量研究。结果:共有5项研究(3项随机对照试验和2项前后研究),包括334名参与者检查了DASH移动应用程序。所有的研究都发现了与DASH智能手机应用程序的使用相关的积极趋势,但这3项随机对照试验有很高的偏倚风险。一项前后研究的偏倚风险高,而另一项的偏倚风险低。因此,关于DASH智能手机应用程序在提高DASH饮食依从性和降低血压方面的有效性,还没有确切的结论。所有的应用程序似乎都可以接受,而且易于使用。结论:使用DASH智能手机应用程序支持自我管理,提高DASH饮食依从性,从而降低血压,这方面的积极作用尚不明显。需要进一步的研究来提供高质量的证据,以确定DASH智能手机应用程序的有效性。
{"title":"The Use of Dietary Approaches to Stop Hypertension (DASH) Mobile Apps for Supporting a Healthy Diet and Controlling Hypertension in Adults: Systematic Review.","authors":"Ghadah Alnooh,&nbsp;Tourkiah Alessa,&nbsp;Mark Hawley,&nbsp;Luc de Witte","doi":"10.2196/35876","DOIUrl":"https://doi.org/10.2196/35876","url":null,"abstract":"<p><strong>Background: </strong>Uncontrolled hypertension is a public health issue, with increasing prevalence worldwide. The Dietary Approaches to Stop Hypertension (DASH) diet is one of the most effective dietary approaches for lowering blood pressure (BP). Dietary mobile apps have gained popularity and are being used to support DASH diet self-management, aiming to improve DASH diet adherence and thus lower BP.</p><p><strong>Objective: </strong>This systematic review aimed to assess the effectiveness of smartphone apps that support self-management to improve DASH diet adherence and consequently reduce BP. A secondary aim was to assess engagement, satisfaction, acceptance, and usability related to DASH mobile app use.</p><p><strong>Methods: </strong>The Embase (OVID), Cochrane Library, CINAHL, Web of Science, Scopus, and Google Scholar electronic databases were used to conduct systematic searches for studies conducted between 2008 and 2021 that used DASH smartphone apps to support self-management. The reference lists of the included articles were also checked. Studies were eligible if they (1) were randomized controlled trials (RCTs) or pre-post studies of app-based interventions for adults (aged 18 years or above) with prehypertension or hypertension, without consideration of gender or sociodemographic characteristics; (2) used mobile phone apps alone or combined with another component, such as communication with others; (3) used or did not use any comparator; and (4) had the primary outcome measures of BP level and adherence to the DASH diet. For eligible studies, data were extracted and outcomes were organized into logical categories, including clinical outcomes (eg, systolic BP, diastolic BP, and weight loss), DASH diet adherence, app usability and acceptability, and user engagement and satisfaction. The quality of the studies was evaluated using the Cochrane Collaboration's Risk of Bias tool for RCTs, and nonrandomized quantitative studies were evaluated using a tool provided by the US National Institutes of Health.</p><p><strong>Results: </strong>A total of 5 studies (3 RCTs and 2 pre-post studies) including 334 participants examined DASH mobile apps. All studies found a positive trend related to the use of DASH smartphone apps, but the 3 RCTs had a high risk of bias. One pre-post study had a high risk of bias, while the other had a low risk. As a consequence, no firm conclusions could be drawn regarding the effectiveness of DASH smartphone apps for increasing DASH diet adherence and lowering BP. All the apps appeared to be acceptable and easy to use.</p><p><strong>Conclusions: </strong>There is weak emerging evidence of a positive effect of using DASH smartphone apps for supporting self-management to improve DASH diet adherence and consequently lower BP. Further research is needed to provide high-quality evidence that can determine the effectiveness of DASH smartphone apps.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e35876"},"PeriodicalIF":0.0,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669886/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40442171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The Impact of Time Horizon on Classification Accuracy: Application of Machine Learning to Prediction of Incident Coronary Heart Disease. 时间范围对分类准确性的影响:机器学习在冠心病事件预测中的应用。
Q2 Medicine Pub Date : 2022-11-02 DOI: 10.2196/38040
Steven Simon, Divneet Mandair, Abdel Albakri, Alison Fohner, Noah Simon, Leslie Lange, Mary Biggs, Kenneth Mukamal, Bruce Psaty, Michael Rosenberg

Background: Many machine learning approaches are limited to classification of outcomes rather than longitudinal prediction. One strategy to use machine learning in clinical risk prediction is to classify outcomes over a given time horizon. However, it is not well-known how to identify the optimal time horizon for risk prediction.

Objective: In this study, we aim to identify an optimal time horizon for classification of incident myocardial infarction (MI) using machine learning approaches looped over outcomes with increasing time horizons. Additionally, we sought to compare the performance of these models with the traditional Framingham Heart Study (FHS) coronary heart disease gender-specific Cox proportional hazards regression model.

Methods: We analyzed data from a single clinic visit of 5201 participants of a cardiovascular health study. We examined 61 variables collected from this baseline exam, including demographic and biologic data, medical history, medications, serum biomarkers, electrocardiographic, and echocardiographic data. We compared several machine learning methods (eg, random forest, L1 regression, gradient boosted decision tree, support vector machine, and k-nearest neighbor) trained to predict incident MI that occurred within time horizons ranging from 500-10,000 days of follow-up. Models were compared on a 20% held-out testing set using area under the receiver operating characteristic curve (AUROC). Variable importance was performed for random forest and L1 regression models across time points. We compared results with the FHS coronary heart disease gender-specific Cox proportional hazards regression functions.

Results: There were 4190 participants included in the analysis, with 2522 (60.2%) female participants and an average age of 72.6 years. Over 10,000 days of follow-up, there were 813 incident MI events. The machine learning models were most predictive over moderate follow-up time horizons (ie, 1500-2500 days). Overall, the L1 (Lasso) logistic regression demonstrated the strongest classification accuracy across all time horizons. This model was most predictive at 1500 days follow-up, with an AUROC of 0.71. The most influential variables differed by follow-up time and model, with gender being the most important feature for the L1 regression and weight for the random forest model across all time frames. Compared with the Framingham Cox function, the L1 and random forest models performed better across all time frames beyond 1500 days.

Conclusions: In a population free of coronary heart disease, machine learning techniques can be used to predict incident MI at varying time horizons with reasonable accuracy, with the strongest prediction accuracy in moderate follow-up periods. Validation across additional populations is needed to confirm the validity of this approach in risk prediction.

背景:许多机器学习方法局限于结果分类,而不是纵向预测。在临床风险预测中使用机器学习的一种策略是在给定的时间范围内对结果进行分类。然而,如何确定风险预测的最佳时间范围并不为人所知。目的:在本研究中,我们的目标是使用机器学习方法在增加的时间范围内循环结果来确定事件心肌梗死(MI)分类的最佳时间范围。此外,我们试图将这些模型的性能与传统的弗雷明汉心脏研究(FHS)冠心病性别特异性Cox比例风险回归模型进行比较。方法:我们分析了5201名心血管健康研究参与者的单次门诊就诊数据。我们检查了从基线检查中收集的61个变量,包括人口统计学和生物学数据、病史、药物、血清生物标志物、心电图和超声心动图数据。我们比较了几种机器学习方法(例如,随机森林、L1回归、梯度增强决策树、支持向量机和k近邻),这些方法经过训练,可以预测在500-10,000天的随访时间范围内发生的MI事件。使用受试者工作特征曲线下面积(AUROC)在20%的测试集上对模型进行比较。对随机森林和L1回归模型进行跨时间点的变量重要性分析。我们将结果与FHS冠心病性别Cox比例风险回归函数进行比较。结果:共纳入4190例受试者,其中女性2522例(60.2%),平均年龄72.6岁。在1万多天的随访中,有813例心梗事件。机器学习模型在中等随访时间范围内(即1500-2500天)最具预测性。总体而言,L1 (Lasso)逻辑回归在所有时间范围内表现出最强的分类准确性。该模型在随访1500天时最具预测性,AUROC为0.71。最具影响力的变量因随访时间和模型而异,性别是L1回归最重要的特征,而随机森林模型的权重在所有时间框架内都是最重要的特征。与Framingham Cox函数相比,L1和随机森林模型在超过1500天的所有时间框架内表现更好。结论:在没有冠心病的人群中,机器学习技术可以在不同的时间范围内以合理的准确性预测心肌梗死的发生,在中等随访期的预测准确性最强。需要在其他人群中进行验证,以确认该方法在风险预测中的有效性。
{"title":"The Impact of Time Horizon on Classification Accuracy: Application of Machine Learning to Prediction of Incident Coronary Heart Disease.","authors":"Steven Simon,&nbsp;Divneet Mandair,&nbsp;Abdel Albakri,&nbsp;Alison Fohner,&nbsp;Noah Simon,&nbsp;Leslie Lange,&nbsp;Mary Biggs,&nbsp;Kenneth Mukamal,&nbsp;Bruce Psaty,&nbsp;Michael Rosenberg","doi":"10.2196/38040","DOIUrl":"https://doi.org/10.2196/38040","url":null,"abstract":"<p><strong>Background: </strong>Many machine learning approaches are limited to classification of outcomes rather than longitudinal prediction. One strategy to use machine learning in clinical risk prediction is to classify outcomes over a given time horizon. However, it is not well-known how to identify the optimal time horizon for risk prediction.</p><p><strong>Objective: </strong>In this study, we aim to identify an optimal time horizon for classification of incident myocardial infarction (MI) using machine learning approaches looped over outcomes with increasing time horizons. Additionally, we sought to compare the performance of these models with the traditional Framingham Heart Study (FHS) coronary heart disease gender-specific Cox proportional hazards regression model.</p><p><strong>Methods: </strong>We analyzed data from a single clinic visit of 5201 participants of a cardiovascular health study. We examined 61 variables collected from this baseline exam, including demographic and biologic data, medical history, medications, serum biomarkers, electrocardiographic, and echocardiographic data. We compared several machine learning methods (eg, random forest, L1 regression, gradient boosted decision tree, support vector machine, and k-nearest neighbor) trained to predict incident MI that occurred within time horizons ranging from 500-10,000 days of follow-up. Models were compared on a 20% held-out testing set using area under the receiver operating characteristic curve (AUROC). Variable importance was performed for random forest and L1 regression models across time points. We compared results with the FHS coronary heart disease gender-specific Cox proportional hazards regression functions.</p><p><strong>Results: </strong>There were 4190 participants included in the analysis, with 2522 (60.2%) female participants and an average age of 72.6 years. Over 10,000 days of follow-up, there were 813 incident MI events. The machine learning models were most predictive over moderate follow-up time horizons (ie, 1500-2500 days). Overall, the L1 (Lasso) logistic regression demonstrated the strongest classification accuracy across all time horizons. This model was most predictive at 1500 days follow-up, with an AUROC of 0.71. The most influential variables differed by follow-up time and model, with gender being the most important feature for the L1 regression and weight for the random forest model across all time frames. Compared with the Framingham Cox function, the L1 and random forest models performed better across all time frames beyond 1500 days.</p><p><strong>Conclusions: </strong>In a population free of coronary heart disease, machine learning techniques can be used to predict incident MI at varying time horizons with reasonable accuracy, with the strongest prediction accuracy in moderate follow-up periods. Validation across additional populations is needed to confirm the validity of this approach in risk prediction.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e38040"},"PeriodicalIF":0.0,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669890/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40442178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Characteristics of Smart Health Ecosystems That Support Self-care Among People With Heart Failure: Scoping Review. 支持心力衰竭患者自我保健的智能健康生态系统的特征:范围审查。
Q2 Medicine Pub Date : 2022-11-02 DOI: 10.2196/36773
Rebecca Nourse, Elton Lobo, Jenna McVicar, Finn Kensing, Sheikh Mohammed Shariful Islam, Lars Kayser, Ralph Maddison

Background: The management of heart failure is complex. Innovative solutions are required to support health care providers and people with heart failure with decision-making and self-care behaviors. In recent years, more sophisticated technologies have enabled new health care models, such as smart health ecosystems. Smart health ecosystems use data collection, intelligent data processing, and communication to support the diagnosis, management, and primary and secondary prevention of chronic conditions. Currently, there is little information on the characteristics of smart health ecosystems for people with heart failure.

Objective: We aimed to identify and describe the characteristics of smart health ecosystems that support heart failure self-care.

Methods: We conducted a scoping review using the Joanna Briggs Institute methodology. The MEDLINE, Embase, CINAHL, PsycINFO, IEEE Xplore, and ACM Digital Library databases were searched from January 2008 to September 2021. The search strategy focused on identifying articles describing smart health ecosystems that support heart failure self-care. A total of 2 reviewers screened the articles and extracted relevant data from the included full texts.

Results: After removing duplicates, 1543 articles were screened, and 34 articles representing 13 interventions were included in this review. To support self-care, the interventions used sensors and questionnaires to collect data and used tailoring methods to provide personalized support. The interventions used a total of 34 behavior change techniques, which were facilitated by a combination of 8 features for people with heart failure: automated feedback, monitoring (integrated and manual input), presentation of data, education, reminders, communication with a health care provider, and psychological support. Furthermore, features to support health care providers included data presentation, alarms, alerts, communication tools, remote care plan modification, and health record integration.

Conclusions: This scoping review identified that there are few reports of smart health ecosystems that support heart failure self-care, and those that have been reported do not provide comprehensive support across all domains of self-care. This review describes the technical and behavioral components of the identified interventions, providing information that can be used as a starting point for designing and testing future smart health ecosystems.

背景:心力衰竭的治疗是复杂的。需要创新的解决方案来支持卫生保健提供者和心力衰竭患者的决策和自我保健行为。近年来,更复杂的技术使智能卫生生态系统等新的卫生保健模式成为可能。智能卫生生态系统利用数据收集、智能数据处理和通信来支持慢性病的诊断、管理和一级和二级预防。目前,关于心力衰竭患者智能健康生态系统特征的信息很少。目的:我们旨在识别和描述支持心力衰竭自我护理的智能健康生态系统的特征。方法:我们使用乔安娜布里格斯研究所的方法进行了范围审查。检索了2008年1月至2021年9月的MEDLINE、Embase、CINAHL、PsycINFO、IEEE explore和ACM数字图书馆数据库。搜索策略侧重于识别描述支持心力衰竭自我护理的智能健康生态系统的文章。共有2名审稿人对文章进行筛选,并从纳入的全文中提取相关数据。结果:剔除重复项后,共筛选1543篇文献,其中34篇文献代表13项干预措施纳入本综述。为了支持自我保健,干预措施使用传感器和问卷收集数据,并使用定制方法提供个性化支持。干预措施总共使用了34种行为改变技术,这些技术通过8种功能的组合来促进心力衰竭患者:自动反馈、监测(集成和手动输入)、数据展示、教育、提醒、与卫生保健提供者的沟通和心理支持。此外,支持医疗保健提供者的功能还包括数据表示、警报、警报、通信工具、远程医疗计划修改和健康记录集成。结论:本范围综述发现,支持心力衰竭自我护理的智能健康生态系统的报道很少,而那些已报道的生态系统并没有为所有领域的自我护理提供全面的支持。本综述描述了已确定干预措施的技术和行为组成部分,提供了可作为设计和测试未来智能卫生生态系统的起点的信息。
{"title":"Characteristics of Smart Health Ecosystems That Support Self-care Among People With Heart Failure: Scoping Review.","authors":"Rebecca Nourse, Elton Lobo, Jenna McVicar, Finn Kensing, Sheikh Mohammed Shariful Islam, Lars Kayser, Ralph Maddison","doi":"10.2196/36773","DOIUrl":"10.2196/36773","url":null,"abstract":"<p><strong>Background: </strong>The management of heart failure is complex. Innovative solutions are required to support health care providers and people with heart failure with decision-making and self-care behaviors. In recent years, more sophisticated technologies have enabled new health care models, such as smart health ecosystems. Smart health ecosystems use data collection, intelligent data processing, and communication to support the diagnosis, management, and primary and secondary prevention of chronic conditions. Currently, there is little information on the characteristics of smart health ecosystems for people with heart failure.</p><p><strong>Objective: </strong>We aimed to identify and describe the characteristics of smart health ecosystems that support heart failure self-care.</p><p><strong>Methods: </strong>We conducted a scoping review using the Joanna Briggs Institute methodology. The MEDLINE, Embase, CINAHL, PsycINFO, IEEE Xplore, and ACM Digital Library databases were searched from January 2008 to September 2021. The search strategy focused on identifying articles describing smart health ecosystems that support heart failure self-care. A total of 2 reviewers screened the articles and extracted relevant data from the included full texts.</p><p><strong>Results: </strong>After removing duplicates, 1543 articles were screened, and 34 articles representing 13 interventions were included in this review. To support self-care, the interventions used sensors and questionnaires to collect data and used tailoring methods to provide personalized support. The interventions used a total of 34 behavior change techniques, which were facilitated by a combination of 8 features for people with heart failure: automated feedback, monitoring (integrated and manual input), presentation of data, education, reminders, communication with a health care provider, and psychological support. Furthermore, features to support health care providers included data presentation, alarms, alerts, communication tools, remote care plan modification, and health record integration.</p><p><strong>Conclusions: </strong>This scoping review identified that there are few reports of smart health ecosystems that support heart failure self-care, and those that have been reported do not provide comprehensive support across all domains of self-care. This review describes the technical and behavioral components of the identified interventions, providing information that can be used as a starting point for designing and testing future smart health ecosystems.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e36773"},"PeriodicalIF":0.0,"publicationDate":"2022-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40442176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Health Care Provider Perspectives on the Use of Mobile Apps to Support Patients With Heart Failure Management: Qualitative Descriptive Study. 评估医疗服务提供者对使用移动应用程序支持心力衰竭患者管理的看法:定性描述性研究
Q2 Medicine Pub Date : 2022-10-26 DOI: 10.2196/40546
Bridve Sivakumar, Manon Lemonde, Matthew Stein, Sarah Goldstein, Susanna Mak, JoAnne Arcand

Background: Nonadherence to diet and medical therapies in heart failure (HF) contributes to poor HF outcomes. Mobile apps may be a promising way to improve adherence because they increase knowledge and behavior change via education and monitoring. Well-designed apps with input from health care providers (HCPs) can lead to successful adoption of such apps in practice. However, little is known about HCPs' perspectives on the use of mobile apps to support HF management.

Objective: The aim of this study is to determine HCPs' perspectives (needs, motivations, and challenges) on the use of mobile apps to support patients with HF management.

Methods: A qualitative descriptive study using one-on-one semistructured interviews, informed by the diffusion of innovation theory, was conducted among HF HCPs, including cardiologists, nurses, and nurse practitioners. Transcripts were independently coded by 2 researchers and analyzed using content analysis.

Results: The 21 HCPs (cardiologists: n=8, 38%; nurses: n=6, 29%; and nurse practitioners: n=7, 33%) identified challenges and opportunities for app adoption across 5 themes: participant-perceived factors that affect app adoption-these include patient age, technology savviness, technology access, and ease of use; improved delivery of care-apps can support remote care; collect, share, and assess health information; identify adverse events; prevent hospitalizations; and limit clinic visits; facilitating patient engagement in care-apps can provide feedback and reinforcement, facilitate connection and communication between patients and their HCPs, support monitoring, and track self-care; providing patient support through education-apps can provide HF-related information (ie, diet and medications); and participant views on app features for their patients-HCPs felt that useful apps would have reminders and alarms and participative elements (gamification, food scanner, and quizzes).

Conclusions: HCPs had positive views on the use of mobile apps to support patients with HF management. These findings can inform effective development and implementation strategies of HF management apps in clinical practice.

背景心力衰竭(HF)患者不坚持饮食和药物治疗会导致HF结果不佳。移动应用程序可能是提高依从性的一种很有前途的方法,因为它们通过教育和监控来增加知识和行为改变。设计良好的应用程序,加上医疗保健提供者(HCP)的投入,可以在实践中成功采用此类应用程序。然而,人们对HCP使用移动应用程序支持HF管理的观点知之甚少。目的本研究的目的是确定HCP对使用移动应用程序支持HF患者管理的看法(需求、动机和挑战)。方法在HF HCP(包括心脏病专家、护士和执业护士)中,采用一对一的半结构访谈进行定性描述性研究,以创新理论的传播为依据。转录本由2名研究人员独立编码,并使用内容分析进行分析。结果21名HCP(心脏病专家:n=8,38%;护士:n=6,29%;执业护士:n=7,33%)在5个主题中确定了应用程序采用的挑战和机会:参与者感知的影响应用程序使用的因素,包括患者年龄、技术知识、技术访问和易用性;改进了护理服务——应用程序可以支持远程护理;收集、共享和评估健康信息;识别不良事件;防止住院;并限制诊所就诊;促进患者参与护理——应用程序可以提供反馈和强化,促进患者与其HCP之间的联系和沟通,支持监测,并跟踪自我护理;通过教育为患者提供支持——应用程序可以提供HF相关信息(即饮食和药物);以及参与者对患者应用程序功能的看法——HCP认为有用的应用程序会有提醒、警报和参与元素(游戏化、食物扫描仪和测验)。结论HCP对使用移动应用程序支持HF患者管理持积极看法。这些发现可以为临床实践中HF管理应用程序的有效开发和实施策略提供信息。
{"title":"Evaluating Health Care Provider Perspectives on the Use of Mobile Apps to Support Patients With Heart Failure Management: Qualitative Descriptive Study.","authors":"Bridve Sivakumar, Manon Lemonde, Matthew Stein, Sarah Goldstein, Susanna Mak, JoAnne Arcand","doi":"10.2196/40546","DOIUrl":"10.2196/40546","url":null,"abstract":"<p><strong>Background: </strong>Nonadherence to diet and medical therapies in heart failure (HF) contributes to poor HF outcomes. Mobile apps may be a promising way to improve adherence because they increase knowledge and behavior change via education and monitoring. Well-designed apps with input from health care providers (HCPs) can lead to successful adoption of such apps in practice. However, little is known about HCPs' perspectives on the use of mobile apps to support HF management.</p><p><strong>Objective: </strong>The aim of this study is to determine HCPs' perspectives (needs, motivations, and challenges) on the use of mobile apps to support patients with HF management.</p><p><strong>Methods: </strong>A qualitative descriptive study using one-on-one semistructured interviews, informed by the diffusion of innovation theory, was conducted among HF HCPs, including cardiologists, nurses, and nurse practitioners. Transcripts were independently coded by 2 researchers and analyzed using content analysis.</p><p><strong>Results: </strong>The 21 HCPs (cardiologists: n=8, 38%; nurses: n=6, 29%; and nurse practitioners: n=7, 33%) identified challenges and opportunities for app adoption across 5 themes: participant-perceived factors that affect app adoption-these include patient age, technology savviness, technology access, and ease of use; improved delivery of care-apps can support remote care; collect, share, and assess health information; identify adverse events; prevent hospitalizations; and limit clinic visits; facilitating patient engagement in care-apps can provide feedback and reinforcement, facilitate connection and communication between patients and their HCPs, support monitoring, and track self-care; providing patient support through education-apps can provide HF-related information (ie, diet and medications); and participant views on app features for their patients-HCPs felt that useful apps would have reminders and alarms and participative elements (gamification, food scanner, and quizzes).</p><p><strong>Conclusions: </strong>HCPs had positive views on the use of mobile apps to support patients with HF management. These findings can inform effective development and implementation strategies of HF management apps in clinical practice.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e40546"},"PeriodicalIF":0.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49500462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiorespiratory Fitness Estimation Based on Heart Rate and Body Acceleration in Adults With Cardiovascular Risk Factors: Validation Study. 有心血管危险因素的成人基于心率和身体加速的心肺健康评估:验证研究。
Q2 Medicine Pub Date : 2022-10-25 DOI: 10.2196/35796
Antti-Pekka E Rissanen, Mirva Rottensteiner, Urho M Kujala, Jari L O Kurkela, Jan Wikgren, Jari A Laukkanen

Background: Cardiorespiratory fitness (CRF) is an independent risk factor for cardiovascular morbidity and mortality. Adding CRF to conventional risk factors (eg, smoking, hypertension, impaired glucose metabolism, and dyslipidemia) improves the prediction of an individual's risk for adverse health outcomes such as those related to cardiovascular disease. Consequently, it is recommended to determine CRF as part of individualized risk prediction. However, CRF is not determined routinely in everyday clinical practice. Wearable technologies provide a potential strategy to estimate CRF on a daily basis, and such technologies, which provide CRF estimates based on heart rate and body acceleration, have been developed. However, the validity of such technologies in estimating individual CRF in clinically relevant populations is poorly known.

Objective: The objective of this study is to evaluate the validity of a wearable technology, which provides estimated CRF based on heart rate and body acceleration, in working-aged adults with cardiovascular risk factors.

Methods: In total, 74 adults (age range 35-64 years; n=56, 76% were women; mean BMI 28.7, SD 4.6 kg/m2) with frequent cardiovascular risk factors (eg, n=64, 86% hypertension; n=18, 24% prediabetes; n=14, 19% type 2 diabetes; and n=51, 69% metabolic syndrome) performed a 30-minute self-paced walk on an indoor track and a cardiopulmonary exercise test on a treadmill. CRF, quantified as peak O2 uptake, was both estimated (self-paced walk: a wearable single-lead electrocardiogram device worn to record continuous beat-to-beat R-R intervals and triaxial body acceleration) and measured (cardiopulmonary exercise test: ventilatory gas analysis). The accuracy of the estimated CRF was evaluated against that of the measured CRF.

Results: Measured CRF averaged 30.6 (SD 6.3; range 20.1-49.6) mL/kg/min. In all participants (74/74, 100%), mean difference between estimated and measured CRF was -0.1 mL/kg/min (P=.90), mean absolute error was 3.1 mL/kg/min (95% CI 2.6-3.7), mean absolute percentage error was 10.4% (95% CI 8.5-12.5), and intraclass correlation coefficient was 0.88 (95% CI 0.80-0.92). Similar accuracy was observed in various subgroups (sexes, age, BMI categories, hypertension, prediabetes, and metabolic syndrome). However, mean absolute error was 4.2 mL/kg/min (95% CI 2.6-6.1) and mean absolute percentage error was 16.5% (95% CI 8.6-24.4) in the subgroup of patients with type 2 diabetes (14/74, 19%).

Conclusions: The error of the CRF estimate, provided by the wearable technology, was likely below or at least very close to the clinically significant level of 3.5 mL/kg/min in working-aged adults with cardiovascular risk factors, but not in the relatively small subgroup of patients with type 2 diabetes. From a large-scale clinical perspective, the findings suggest that weara

背景:心肺适能(CRF)是心血管疾病发病率和死亡率的独立危险因素。将CRF添加到常规危险因素(如吸烟、高血压、糖代谢受损和血脂异常)中,可以改善对个人不良健康结果(如与心血管疾病相关的健康结果)风险的预测。因此,建议将CRF作为个体化风险预测的一部分。然而,在日常临床实践中,CRF并不是常规的。可穿戴技术为每天估计CRF提供了一种潜在的策略,这种技术可以根据心率和身体加速度来估计CRF。然而,这些技术在临床相关人群中评估个体CRF的有效性尚不清楚。目的:本研究的目的是评估可穿戴技术的有效性,该技术可根据心率和身体加速度提供具有心血管危险因素的工作年龄成年人的CRF估计。方法:74例成人(年龄35 ~ 64岁;N =56, 76%为女性;平均BMI 28.7, SD 4.6 kg/m2),心血管危险因素较多(例如,n=64,高血压86%;N =18, 24%为前驱糖尿病;N =14, 19%为2型糖尿病;n=51, 69%代谢综合征)在室内跑道上进行30分钟的自定节奏步行,并在跑步机上进行心肺运动测试。CRF被量化为峰值氧摄取,评估(自定步走:一种可穿戴的单导联心电图设备,用于记录连续搏动R-R间隔和三轴体加速度)和测量(心肺运动试验:通气气体分析)。根据测量的CRF来评估估计CRF的准确性。结果:测量CRF平均30.6 (SD 6.3;范围:20.1-49.6)mL/kg/min。在所有参与者(74/74,100%)中,估计的CRF和测量的CRF之间的平均差异为-0.1 mL/kg/min (P= 0.90),平均绝对误差为3.1 mL/kg/min (95% CI 2.6-3.7),平均绝对百分比误差为10.4% (95% CI 8.5-12.5),类内相关系数为0.88 (95% CI 0.80-0.92)。在不同亚组(性别、年龄、BMI类别、高血压、前驱糖尿病和代谢综合征)中观察到类似的准确性。然而,2型糖尿病患者亚组的平均绝对误差为4.2 mL/kg/min (95% CI 2.6-6.1),平均绝对百分比误差为16.5% (95% CI 8.6-24.4)(14/ 74,19 %)。结论:可穿戴技术提供的CRF估计误差可能低于或至少非常接近具有心血管危险因素的工作年龄成年人的临床显著水平3.5 mL/kg/min,但在相对较小的2型糖尿病患者亚组中则不然。从大规模的临床角度来看,研究结果表明,可穿戴技术有可能在临床相关人群中以可接受的准确性估计个体CRF。
{"title":"Cardiorespiratory Fitness Estimation Based on Heart Rate and Body Acceleration in Adults With Cardiovascular Risk Factors: Validation Study.","authors":"Antti-Pekka E Rissanen,&nbsp;Mirva Rottensteiner,&nbsp;Urho M Kujala,&nbsp;Jari L O Kurkela,&nbsp;Jan Wikgren,&nbsp;Jari A Laukkanen","doi":"10.2196/35796","DOIUrl":"https://doi.org/10.2196/35796","url":null,"abstract":"<p><strong>Background: </strong>Cardiorespiratory fitness (CRF) is an independent risk factor for cardiovascular morbidity and mortality. Adding CRF to conventional risk factors (eg, smoking, hypertension, impaired glucose metabolism, and dyslipidemia) improves the prediction of an individual's risk for adverse health outcomes such as those related to cardiovascular disease. Consequently, it is recommended to determine CRF as part of individualized risk prediction. However, CRF is not determined routinely in everyday clinical practice. Wearable technologies provide a potential strategy to estimate CRF on a daily basis, and such technologies, which provide CRF estimates based on heart rate and body acceleration, have been developed. However, the validity of such technologies in estimating individual CRF in clinically relevant populations is poorly known.</p><p><strong>Objective: </strong>The objective of this study is to evaluate the validity of a wearable technology, which provides estimated CRF based on heart rate and body acceleration, in working-aged adults with cardiovascular risk factors.</p><p><strong>Methods: </strong>In total, 74 adults (age range 35-64 years; n=56, 76% were women; mean BMI 28.7, SD 4.6 kg/m<sup>2</sup>) with frequent cardiovascular risk factors (eg, n=64, 86% hypertension; n=18, 24% prediabetes; n=14, 19% type 2 diabetes; and n=51, 69% metabolic syndrome) performed a 30-minute self-paced walk on an indoor track and a cardiopulmonary exercise test on a treadmill. CRF, quantified as peak O<sub>2</sub> uptake, was both estimated (self-paced walk: a wearable single-lead electrocardiogram device worn to record continuous beat-to-beat R-R intervals and triaxial body acceleration) and measured (cardiopulmonary exercise test: ventilatory gas analysis). The accuracy of the estimated CRF was evaluated against that of the measured CRF.</p><p><strong>Results: </strong>Measured CRF averaged 30.6 (SD 6.3; range 20.1-49.6) mL/kg/min. In all participants (74/74, 100%), mean difference between estimated and measured CRF was -0.1 mL/kg/min (P=.90), mean absolute error was 3.1 mL/kg/min (95% CI 2.6-3.7), mean absolute percentage error was 10.4% (95% CI 8.5-12.5), and intraclass correlation coefficient was 0.88 (95% CI 0.80-0.92). Similar accuracy was observed in various subgroups (sexes, age, BMI categories, hypertension, prediabetes, and metabolic syndrome). However, mean absolute error was 4.2 mL/kg/min (95% CI 2.6-6.1) and mean absolute percentage error was 16.5% (95% CI 8.6-24.4) in the subgroup of patients with type 2 diabetes (14/74, 19%).</p><p><strong>Conclusions: </strong>The error of the CRF estimate, provided by the wearable technology, was likely below or at least very close to the clinically significant level of 3.5 mL/kg/min in working-aged adults with cardiovascular risk factors, but not in the relatively small subgroup of patients with type 2 diabetes. From a large-scale clinical perspective, the findings suggest that weara","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e35796"},"PeriodicalIF":0.0,"publicationDate":"2022-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40669373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium. CARRIER联盟提出的减少动脉粥样硬化性心血管疾病负担的数字健康解决方案。
Q2 Medicine Pub Date : 2022-10-17 DOI: 10.2196/37437
Bart Scheenstra, Anke Bruninx, Florian van Daalen, Nina Stahl, Elizabeth Latuapon, Maike Imkamp, Lianne Ippel, Sulaika Duijsings-Mahangi, Djura Smits, David Townend, Inigo Bermejo, Andre Dekker, Laura Hochstenbach, Marieke Spreeuwenberg, Jos Maessen, Arnoud van 't Hof, Bas Kietselaer

Digital health is a promising tool to support people with an elevated risk for atherosclerotic cardiovascular disease (ASCVD) and patients with an established disease to improve cardiovascular outcomes. Many digital health initiatives have been developed and employed. However, barriers to their large-scale implementation have remained. This paper focuses on these barriers and presents solutions as proposed by the Dutch CARRIER (ie, Coronary ARtery disease: Risk estimations and Interventions for prevention and EaRly detection) consortium. We will focus in 4 sections on the following: (1) the development process of an eHealth solution that will include design thinking and cocreation with relevant stakeholders; (2) the modeling approach for two clinical prediction models (CPMs) to identify people at risk of developing ASCVD and to guide interventions; (3) description of a federated data infrastructure to train the CPMs and to provide the eHealth solution with relevant data; and (4) discussion of an ethical and legal framework for responsible data handling in health care. The Dutch CARRIER consortium consists of a collaboration between experts in the fields of eHealth development, ASCVD, public health, big data, as well as ethics and law. The consortium focuses on reducing the burden of ASCVD. We believe the future of health care is data driven and supported by digital health. Therefore, we hope that our research will not only facilitate CARRIER consortium but may also facilitate other future health care initiatives.

数字健康是一种很有前途的工具,可以帮助动脉粥样硬化性心血管疾病(ASCVD)风险升高的人群和已确诊疾病的患者改善心血管预后。已经制定和采用了许多数字卫生倡议。然而,大规模实施的障碍仍然存在。本文重点讨论了这些障碍,并提出了荷兰CARRIER(即冠状动脉疾病:预防和早期检测的风险评估和干预措施)联盟提出的解决方案。我们将分4个部分重点介绍以下内容:(1)电子健康解决方案的开发过程,包括设计思维和与相关利益相关者的共同创造;(2)两种临床预测模型(CPMs)的建模方法,用于识别ASCVD风险人群并指导干预;(3)描述了一个联邦数据基础设施,用于训练cpm并为eHealth解决方案提供相关数据;(4)讨论卫生保健中负责任的数据处理的道德和法律框架。荷兰CARRIER联盟由电子健康发展、ASCVD、公共卫生、大数据以及伦理和法律领域的专家组成。该联盟致力于减轻ASCVD的负担。我们相信,医疗保健的未来是由数据驱动和数字健康支持的。因此,我们希望我们的研究不仅可以促进CARRIER联盟,还可以促进其他未来的医疗保健倡议。
{"title":"Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium.","authors":"Bart Scheenstra,&nbsp;Anke Bruninx,&nbsp;Florian van Daalen,&nbsp;Nina Stahl,&nbsp;Elizabeth Latuapon,&nbsp;Maike Imkamp,&nbsp;Lianne Ippel,&nbsp;Sulaika Duijsings-Mahangi,&nbsp;Djura Smits,&nbsp;David Townend,&nbsp;Inigo Bermejo,&nbsp;Andre Dekker,&nbsp;Laura Hochstenbach,&nbsp;Marieke Spreeuwenberg,&nbsp;Jos Maessen,&nbsp;Arnoud van 't Hof,&nbsp;Bas Kietselaer","doi":"10.2196/37437","DOIUrl":"https://doi.org/10.2196/37437","url":null,"abstract":"<p><p>Digital health is a promising tool to support people with an elevated risk for atherosclerotic cardiovascular disease (ASCVD) and patients with an established disease to improve cardiovascular outcomes. Many digital health initiatives have been developed and employed. However, barriers to their large-scale implementation have remained. This paper focuses on these barriers and presents solutions as proposed by the Dutch CARRIER (ie, Coronary ARtery disease: Risk estimations and Interventions for prevention and EaRly detection) consortium. We will focus in 4 sections on the following: (1) the development process of an eHealth solution that will include design thinking and cocreation with relevant stakeholders; (2) the modeling approach for two clinical prediction models (CPMs) to identify people at risk of developing ASCVD and to guide interventions; (3) description of a federated data infrastructure to train the CPMs and to provide the eHealth solution with relevant data; and (4) discussion of an ethical and legal framework for responsible data handling in health care. The Dutch CARRIER consortium consists of a collaboration between experts in the fields of eHealth development, ASCVD, public health, big data, as well as ethics and law. The consortium focuses on reducing the burden of ASCVD. We believe the future of health care is data driven and supported by digital health. Therefore, we hope that our research will not only facilitate CARRIER consortium but may also facilitate other future health care initiatives.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":" ","pages":"e37437"},"PeriodicalIF":0.0,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623459/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33519000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
JMIR Cardio
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1